HEADER TRANSFERASE 19-NOV-01 1KF0 TITLE CRYSTAL STRUCTURE OF PIG MUSCLE PHOSPHOGLYCERATE KINASE TERNARY TITLE 2 COMPLEX WITH AMP-PCP AND 3PG COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHOGLYCERATE KINASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.2.3 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 OTHER_DETAILS: MUSCLE KEYWDS ATP ANALOGUE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Z.KOVARI,B.FLACHNER,G.NARAY-SZABO,M.VAS REVDAT 4 03-APR-24 1KF0 1 REMARK REVDAT 3 07-FEB-24 1KF0 1 REMARK LINK REVDAT 2 24-FEB-09 1KF0 1 VERSN REVDAT 1 24-JUL-02 1KF0 0 JRNL AUTH Z.KOVARI,B.FLACHNER,G.NARAY-SZABO,M.VAS JRNL TITL CRYSTALLOGRAPHIC AND THIOL-REACTIVITY STUDIES ON THE COMPLEX JRNL TITL 2 OF PIG MUSCLE PHOSPHOGLYCERATE KINASE WITH ATP ANALOGUES: JRNL TITL 3 CORRELATION BETWEEN NUCLEOTIDE BINDING MODE AND HELIX JRNL TITL 4 FLEXIBILITY. JRNL REF BIOCHEMISTRY V. 41 8796 2002 JRNL REFN ISSN 0006-2960 JRNL PMID 12102622 JRNL DOI 10.1021/BI020210J REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 10666 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 609 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 48.08 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1249 REMARK 3 BIN FREE R VALUE : 0.3722 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 36 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3032 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.07500 REMARK 3 B22 (A**2) : -5.43700 REMARK 3 B33 (A**2) : -4.45900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.88000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 BOND ANGLES (DEGREES) : 0.842 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.05 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.500 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1KF0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-NOV-01. REMARK 100 THE DEPOSITION ID IS D_1000014883. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-APR-96 REMARK 200 TEMPERATURE (KELVIN) : 297 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12274 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.25200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PIG MUSCLE PGK TERNARY COMPLEX WITH MNAMP-PNP AND REMARK 200 3-PG MAY ET AL., PROTEINS, 24:292-303, 1996) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MAGNESIUM CHLORIDE, PEG 8000, PH 7.0, REMARK 280 288K, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 55.15000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 29 CG CD CE NZ REMARK 470 ASN A 30 CB CG OD1 ND2 REMARK 470 ASN A 31 CG OD1 ND2 REMARK 470 GLN A 32 CB CG CD OE1 NE2 REMARK 470 GLN A 37 CG CD OE1 NE2 REMARK 470 LYS A 47 CG CD CE NZ REMARK 470 LYS A 74 CB CG CD CE NZ REMARK 470 LYS A 85 CD CE NZ REMARK 470 LYS A 96 CG CD CE NZ REMARK 470 LYS A 130 CB CG CD CE NZ REMARK 470 LYS A 138 CG CD CE NZ REMARK 470 LYS A 140 CG CD CE NZ REMARK 470 LYS A 147 CG CD CE NZ REMARK 470 THR A 148 OG1 CG2 REMARK 470 ASN A 179 CB CG OD1 ND2 REMARK 470 LYS A 215 CD CE NZ REMARK 470 GLU A 273 CG CD OE1 OE2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 LYS A 352 CD CE NZ REMARK 470 ARG A 364 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 381 CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 30 -19.92 -168.48 REMARK 500 ASN A 31 1.73 178.62 REMARK 500 ASN A 120 111.89 -31.57 REMARK 500 ALA A 171 53.40 -97.24 REMARK 500 ALA A 199 39.69 -99.18 REMARK 500 LEU A 200 -19.71 -159.32 REMARK 500 SER A 202 78.63 -158.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 518 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 218 OD1 REMARK 620 2 ACP A 418 O2B 173.5 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 518 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3PG A 417 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACP A 418 REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE AUTHOR REMARK STATES THAT THE PIG PHOSPHOGLYCERATE REMARK 999 KINASE (PGK) HAS NOT YET BEEN SEQUENCED. THEREFORE THE REMARK 999 SEQUENCE OF THE STRUCTURE IS BASED ON THE SEQUENCE OF THE REMARK 999 HORSE MUSCLE PGK AND ON THE INTERPRETATION OF THE ELECTRON REMARK 999 DENSITY MAPS. DBREF 1KF0 A 1 416 UNP Q7SIB7 PGK1_PIG 1 416 SEQRES 1 A 416 SER LEU SER ASN LYS LEU THR LEU ASP LYS LEU ASN VAL SEQRES 2 A 416 LYS GLY LYS ARG VAL VAL MET ARG VAL ASP PHE ASN VAL SEQRES 3 A 416 PRO MET LYS ASN ASN GLN ILE THR ASN ASN GLN ARG ILE SEQRES 4 A 416 LYS ALA ALA VAL PRO SER ILE LYS PHE CYS LEU ASP ASP SEQRES 5 A 416 GLY ALA LYS SER VAL VAL LEU MET SER HIS LEU GLY ARG SEQRES 6 A 416 PRO ASP GLY SER PRO MET PRO ASP LYS TYR SER LEU GLN SEQRES 7 A 416 PRO VAL ALA VAL GLU LEU LYS SER LEU LEU GLY LYS ASP SEQRES 8 A 416 VAL LEU PHE LEU LYS ASP CYS VAL GLY PRO GLU VAL GLU SEQRES 9 A 416 LYS ALA CYS ALA ASP PRO ALA ALA GLY SER VAL ILE LEU SEQRES 10 A 416 LEU GLU ASN LEU ARG PHE HIS VAL GLU GLU GLU GLY LYS SEQRES 11 A 416 GLY LYS ASP ALA SER GLY ASN LYS VAL LYS ALA GLU PRO SEQRES 12 A 416 ALA LYS ILE LYS THR PHE ARG ALA SER LEU SER LYS LEU SEQRES 13 A 416 GLY ASP VAL TYR VAL ASN ASP ALA PHE GLY THR ALA HIS SEQRES 14 A 416 ARG ALA HIS SER SER MET VAL GLY VAL ASN LEU PRO LYS SEQRES 15 A 416 LYS ALA GLY GLY PHE LEU MET LYS LYS GLU LEU ASN TYR SEQRES 16 A 416 PHE ALA LYS ALA LEU GLU SER PRO GLU ARG PRO PHE LEU SEQRES 17 A 416 ALA ILE LEU GLY GLY ALA LYS VAL ALA ASP LYS ILE GLN SEQRES 18 A 416 LEU ILE ASN ASN MET LEU ASP LYS VAL ASN GLU MET ILE SEQRES 19 A 416 ILE GLY GLY GLY MET ALA PHE THR PHE LEU LYS VAL LEU SEQRES 20 A 416 ASN ASN MET GLU ILE GLY THR SER LEU PHE ASP GLU GLU SEQRES 21 A 416 GLY ALA LYS ILE VAL LYS ASN LEU MET SER LYS ALA GLU SEQRES 22 A 416 LYS ASN GLY VAL LYS ILE THR LEU PRO VAL ASP PHE VAL SEQRES 23 A 416 THR ALA ASP LYS PHE ASP GLU HIS ALA LYS THR GLY GLN SEQRES 24 A 416 ALA THR VAL ALA SER GLY ILE PRO ALA GLY TRP MET GLY SEQRES 25 A 416 LEU ASP CYS GLY PRO GLU SER SER LYS LYS TYR SER GLU SEQRES 26 A 416 ALA VAL ALA ARG ALA LYS GLN ILE VAL TRP ASN GLY PRO SEQRES 27 A 416 VAL GLY VAL PHE GLU TRP GLU ALA PHE ALA GLN GLY THR SEQRES 28 A 416 LYS ALA LEU MET ASP GLU VAL VAL LYS ALA THR SER ARG SEQRES 29 A 416 GLY CYS ILE THR ILE ILE GLY GLY GLY ASP THR ALA THR SEQRES 30 A 416 CYS CYS ALA LYS TRP ASN THR GLU ASP LYS VAL SER HIS SEQRES 31 A 416 VAL SER THR GLY GLY GLY ALA SER LEU GLU LEU LEU GLU SEQRES 32 A 416 GLY LYS VAL LEU PRO GLY VAL ASP ALA LEU SER ASN VAL HET MG A 518 1 HET 3PG A 417 11 HET ACP A 418 31 HETNAM MG MAGNESIUM ION HETNAM 3PG 3-PHOSPHOGLYCERIC ACID HETNAM ACP PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER HETSYN ACP ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE FORMUL 2 MG MG 2+ FORMUL 3 3PG C3 H7 O7 P FORMUL 4 ACP C11 H18 N5 O12 P3 FORMUL 5 HOH *81(H2 O) HELIX 1 1 THR A 7 LEU A 11 5 5 HELIX 2 2 ASN A 36 ALA A 41 1 6 HELIX 3 3 ALA A 42 ASP A 52 1 11 HELIX 4 4 LEU A 77 GLY A 89 1 13 HELIX 5 5 GLY A 100 CYS A 107 1 8 HELIX 6 6 ASN A 120 HIS A 124 5 5 HELIX 7 7 GLU A 142 LEU A 156 1 15 HELIX 8 8 ALA A 164 ALA A 168 5 5 HELIX 9 9 HIS A 172 GLY A 177 1 6 HELIX 10 10 GLY A 186 ALA A 199 1 14 HELIX 11 11 VAL A 216 ASP A 218 5 3 HELIX 12 12 LYS A 219 LEU A 227 1 9 HELIX 13 13 GLY A 237 ASN A 249 1 13 HELIX 14 14 ASP A 258 LYS A 263 1 6 HELIX 15 15 ILE A 264 GLY A 276 1 13 HELIX 16 16 GLY A 316 ALA A 330 1 15 HELIX 17 17 TRP A 344 PHE A 347 5 4 HELIX 18 18 ALA A 348 SER A 363 1 16 HELIX 19 19 GLY A 373 LYS A 381 1 9 HELIX 20 20 GLY A 394 GLU A 403 1 10 HELIX 21 21 LEU A 407 ALA A 412 1 6 SHEET 1 A 6 LEU A 93 PHE A 94 0 SHEET 2 A 6 SER A 114 LEU A 117 1 O VAL A 115 N LEU A 93 SHEET 3 A 6 SER A 56 MET A 60 1 N LEU A 59 O ILE A 116 SHEET 4 A 6 ARG A 17 ARG A 21 1 N VAL A 18 O VAL A 58 SHEET 5 A 6 VAL A 159 ASN A 162 1 O VAL A 161 N VAL A 19 SHEET 6 A 6 LYS A 183 GLY A 185 1 O ALA A 184 N TYR A 160 SHEET 1 B 2 LYS A 130 LYS A 132 0 SHEET 2 B 2 LYS A 138 LYS A 140 -1 O VAL A 139 N GLY A 131 SHEET 1 C 6 LYS A 278 THR A 280 0 SHEET 2 C 6 GLU A 232 ILE A 235 1 N MET A 233 O THR A 280 SHEET 3 C 6 PHE A 207 LEU A 211 1 N LEU A 211 O ILE A 234 SHEET 4 C 6 GLN A 332 ASN A 336 1 O VAL A 334 N ILE A 210 SHEET 5 C 6 ILE A 367 ILE A 370 1 O ILE A 367 N ILE A 333 SHEET 6 C 6 HIS A 390 VAL A 391 1 O HIS A 390 N ILE A 370 SHEET 1 D 3 THR A 297 THR A 301 0 SHEET 2 D 3 ASP A 284 ALA A 288 -1 N PHE A 285 O ALA A 300 SHEET 3 D 3 MET A 311 CYS A 315 -1 O ASP A 314 N VAL A 286 LINK OD1 ASP A 218 MG MG A 518 1555 1555 2.25 LINK O2B ACP A 418 MG MG A 518 1555 1555 2.23 CISPEP 1 ARG A 205 PRO A 206 0 -0.07 SITE 1 AC1 2 ASP A 218 ACP A 418 SITE 1 AC2 11 ASP A 23 ASN A 25 ARG A 38 HIS A 62 SITE 2 AC2 11 ARG A 65 ARG A 122 GLY A 166 ARG A 170 SITE 3 AC2 11 HOH A 451 HOH A 476 HOH A 500 SITE 1 AC3 16 GLY A 213 ALA A 214 LYS A 215 LYS A 219 SITE 2 AC3 16 GLY A 237 GLY A 238 PHE A 241 GLY A 312 SITE 3 AC3 16 GLY A 340 VAL A 341 GLU A 343 ASP A 374 SITE 4 AC3 16 HOH A 426 HOH A 467 HOH A 506 MG A 518 CRYST1 36.600 110.300 48.000 90.00 93.90 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027322 0.000000 0.001863 0.00000 SCALE2 0.000000 0.009066 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020882 0.00000